•  
  •  
 

Florida State University Journal of Transnational Law & Policy

Authors

Jonathan Carr

Abstract

In an attempt to unify the regulation of intellectual property, the TRIPS Agreement sets forth standards for intellectual property law. Recently, however, many countries have become divided on the issue of whether member countries should be required to disclose the source and origin of genetic resources used in patented technologies. Developing countries claim that enforcement of such a requirement would help remedy the global biopiracy problem. This article reviews and assesses the many proposals to amend the TRIPS Agreement as well as the responses from countries, such as the United States, opposing the proposals. Included is a brief discussion about the potential economic ramifications of such an amendment to TRIPS and discussion of alternative international agreements as potential venues for a similar disclosure requirement.

Share

COinS